BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3959805)

  • 1. [Relation of blood serum ferritin and ferritin-bearing lymphocytes in breast cancer].
    Chernovskaia EM; Polevaia EB; Tuzhikova NK
    Med Radiol (Mosk); 1986 Apr; 31(4):15-7. PubMed ID: 3959805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of evaluating tumor markers: CA 15-3 and ferritin in blood serum of patients grouped as "high risk" for breast cancer].
    Kokocińska D; Widala E; Donocik J; Nolewajka E
    Przegl Lek; 1999; 56(10):664-7. PubMed ID: 10695382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay.
    Bluestein BI; Luderer AA; Hess D; Smith D; Meyer KK; Boyle G; Carter AC
    Cancer Res; 1984 Sep; 44(9):4131-6. PubMed ID: 6744324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary observations on the behavior of serum ferritin in female patients with breast cancer at various stages of the disease].
    Dell'Anna B; Carnevali C; Crialesi Esposito G; Percudani M
    Acta Biomed Ateneo Parmense; 1982; 53(3):147-51. PubMed ID: 6216702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor cel activity of ferritin-bearing lymphocytes in patients with breast cancer.
    Moroz C; Kupfer B
    Isr J Med Sci; 1981; 17(9-10):879-81. PubMed ID: 6458580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum ferritin level in patients with breast cancer].
    Rusinowska Z; Rozek-Lesiak K; Kokocińska D
    Pol Tyg Lek; 1988 May; 43(22):706-8. PubMed ID: 3226979
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast.
    Kher A; Moghe G; Deshpande A
    Indian J Pathol Microbiol; 1997 Jul; 40(3):321-6. PubMed ID: 9354001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What value should be given to assays of serum ferritin in breast cancers? Correlation with various biological parameters].
    Dalifard I; Daver A; Cellier P; Larra F
    Sem Hop; 1984 Jan; 60(3):157-62. PubMed ID: 6320439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of serum ferritin to concanavalin A in patients with malignancy.
    Muylle L; Blockx P; Becquart D
    Biomed Pharmacother; 1986; 40(6):225-7. PubMed ID: 3790716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin in Nigerian patients with Burkitt's lymphoma and other malignant diseases.
    Bolarin DM
    Acta Trop; 1983 Mar; 40(1):71-7. PubMed ID: 6134456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of ferritin in malignant diseases.
    Giler S; Moroz C
    Biomedicine; 1978; 28(4):203-6. PubMed ID: 737272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.
    Pattanapanyasat K; Hoy TG; Jacobs A; Courtney S; Webster DJ
    Br J Cancer; 1988 Feb; 57(2):193-7. PubMed ID: 2965916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ferritin and breast cancer].
    Claustres M; Belaroussi N; Guilleux F; Magnan de Bornier B
    Pathol Biol (Paris); 1984 Apr; 32(4):265-8. PubMed ID: 6718068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum parameters of iron metabolism in patients with breast cancer.
    Ulbrich EJ; Lebrecht A; Schneider I; Ludwig E; Koelbl H; Hefler LA
    Anticancer Res; 2003; 23(6D):5107-9. PubMed ID: 14981974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferritin levels and circulating immune complexes in patients with solid tumors.
    Celada A; Barnet M; Aguado MT; Cruchaud A; Lambert PH
    Bull Cancer; 1982; 69(1):22-7. PubMed ID: 6978747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on serum immunosuppressive factors in gastric cancer patients--with special reference to preoperative ferritin levels and influence of surgical stress].
    Yokoyama Y; Saji S; Misao H; Kunii Y; Kajima T; Kunieda K; Nishiwaki T; Adachi Y; Kawata R; Sakata K
    Gan No Rinsho; 1985 Sep; 31(11):1387-92. PubMed ID: 4068240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC; Wang F; Elliott RL; Head JF
    Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte labile iron pool, plasma iron, transferrin saturation and ferritin levels in colon cancer patients.
    Gackowski D; Kruszewsk M; Banaszkiewicz Z; Jawien A; Olinski R
    Acta Biochim Pol; 2002; 49(1):269-72. PubMed ID: 12136950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association of serum tumor markers in solid neoplasms (CEA, ferritin, alpha 1-antitrypsin, parathormone and calcitonin)].
    Di Martino G; Iannucci F; Bizzarro A; Iacono G
    Boll Ist Sieroter Milan; 1982; 61(5):411-22. PubMed ID: 6985416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ferritin in breast cancer].
    Góźdź S; Słuszniak J; Bukowski J; Zagała A; Kowalski D; Korejba W; Banasińska E; Cheba L
    Pol Tyg Lek; 1986 Sep; 41(35):1110-2. PubMed ID: 3797346
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.